Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior.

Published in: Biomolecules (2023)

These proof-of-concept findings suggest a promising strategy for administering TKIs in a more targeted and effective manner.

Keyphrases